Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment - Wikidata - wikimedia - TriplyDB

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

http://www.wikidata.org/entity/Q28211825

about

sameAs

Kynurenines in CNS disease: regulation by inflammatory cytokines Antidepressants for the treatment of depression in people with cancer Cytokine, sickness behavior, and depression Exploring the Physiological Link between Psoriasis and Mood Disorders Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review Depression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatment A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms Immunomodulatory properties of cacao extracts - potential consequences for medical applications Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise Kynurenines in the mammalian brain: when physiology meets pathology Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior Biochemical markers subtyping major depressive disorder Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Depression and immunity: a role for T cells?Enhanced cognitive function and antidepressant-like effects after krill oil supplementation in rats.The relationship of alcohol use disorders and depressive symptoms to tryptophan metabolism: cross-sectional data from a Nepalese alcohol treatment sample.Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?Psychiatric clearance for patients started on interferon-alpha-based therapies.Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain.Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior.Cytokine, sickness behavior, and depression.Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.Neuropsychiatric adverse effects of interferon-alpha: recognition and management.Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression Inflammation-associated depression: from serotonin to kynurenine Citalopram reduces endotoxin-induced fatigue.No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C.Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts Immune system to brain signaling: neuropsychopharmacological implications.Inflammatory cytokine-associated depression Toward an anti-inflammatory strategy for depression The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C Major depression during interferon-alpha treatment: vulnerability and prevention.

P2860

Q21129356-793804A8-AB81-4655-9DD6-9EE6BEC6B752 Q24187358-5B31552D-76BC-4EC3-8FB4-94CC0170A86B Q24657818-B90F7761-DC92-4ECA-89A7-8145068258F3 Q26778531-5D522E75-CB6F-4B05-9A99-285791CA5BD1 Q26782993-4575D977-9EC8-49CF-9AD3-34502ACF2B81 Q26783698-69A815A6-F138-4FF3-8657-AA4128E702CB Q26786354-BB6B0E70-EB2C-4440-872F-9C793AF0D950 Q26800052-C54FE47E-DCDD-40C7-9604-978697F5279D Q26853328-B9CF703D-24FF-4703-B7E8-BB7590AD0795 Q27001628-B8A993D1-B5E8-4F14-999A-044F41DDB1F9 Q27003296-D9CD5639-AF97-4FAC-8EF5-C308E4FC9F19 Q27694728-C54C3959-B1B0-4EC8-B449-66EB5403D93A Q28081652-BDB21369-2BC6-450D-A5CF-B57FE5433617 Q29617326-530F0FD3-6165-482B-AC38-241B019CB1DB Q30477752-602EF187-0ADC-41DE-9FE9-CB5A7B6D1383 Q30538444-1181B22C-4332-4616-9E9F-2277AA6DD2A0 Q30886912-2CF90121-46F3-41C9-805B-19BA0F013410 Q31141746-BAB6AD7B-A9AD-4522-BC1E-F5B99AB3C3D3 Q33379228-01795B39-291E-4D2C-8ECC-32C69E258F6A Q33624724-9C673BC1-C0E7-479B-B706-D8B444B549E8 Q33645706-34D5DEB7-C644-44CB-BEEE-5E07D1120792 Q33708662-2609AC67-1C69-4E33-9A32-3141CFA4D35A Q33715452-AB0A48DF-256E-4840-8C07-A08B8F805F71 Q33751166-1C3CF292-8FC0-46E9-B754-AB736FDDF2DF Q33863747-120AF24D-FB73-4C94-8F2F-F186B872B1EF Q34012783-39E32475-EA11-4445-B728-A29D8D9DE379 Q34018621-A38BF5B0-47F6-4FC5-B973-E4EE8FD296A2 Q34078917-FCD96D6D-84D3-4D61-B330-33A947485227 Q34081783-F6699946-A861-47D7-A801-EED8E2448839 Q34090453-99EEFAA2-661C-4C43-8DE1-68518B4CED87 Q34147377-DC99362F-1C3B-4BCB-B7D0-E12C7C6DAC14 Q34511076-310FCD57-C5CD-458F-8940-6B9163389B4E Q34511200-8760DFE9-24FE-48D7-A61D-21D54C44472A Q34594318-E7A81732-F269-496C-A712-8AE9A1E21FCB Q34769827-F186D6D7-D070-4566-ACC5-47C4E1C3ADDE Q34825010-261CFA75-F4F0-4B83-836A-419275092360 Q34852990-AB08FC54-0029-4714-B507-C22AA4AC5EBE Q34996746-F9AD49E1-D41E-498E-AE7C-E1AA0B3AF873 Q35231633-92C4506C-4C36-4466-BA1C-6357BC0A01F9 Q35237145-C17CA9D6-ECF0-431E-A795-95342E1EEB8E

P2860

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

http://www.wikidata.org/entity/Q28211825

description

2003 nî lūn-bûn

@nan

2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@ast

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@en

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@nl

type

label

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@ast

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@en

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@nl

prefLabel

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@ast

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@en

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@nl

P1433

Q28211825-F5365398-333C-4E4F-A3F2-76C3CE240F9F

P1476

Q28211825-02AD863D-C58E-4602-A957-718FD8FD5599

P2093

Q28211825-28977753-C73E-47AA-ADA0-7D9E19DB77F7

Q28211825-7FB6AD75-1676-40FE-BD0A-86E924F2D718

Q28211825-88D26664-2862-41A9-AF0F-E8257E8FEEBE

Q28211825-8D17622C-B81B-46FE-A053-8838B3983DE9

Q28211825-B5EA2221-A4C8-40CB-8E8F-D80F82F421D1

Q28211825-C3AD3C03-2346-4C28-BCC9-46CDC5B55234

P304

Q28211825-EB1CE2B9-3340-4E3F-84D7-B72CE4CC7FAF

P31

Q28211825-18E0CB30-EAFB-4AE6-8B4F-7D14090137BE

P3181

Q28211825-B7C30D8A-71DE-46F2-8192-20D66094B57D

P356

Q28211825-45E57604-47A2-4C80-B334-C1F6AAC890AA

P407

Q28211825-5C89C307-2115-43E5-A39A-DF77CFC85112

P433

Q28211825-BB2120B5-44AC-4E86-A485-E9323F7A3801

P478

Q28211825-E03C38BC-4C2E-4DCE-97DA-8FFA921540CA

P50

Q28211825-4E03D7C8-A912-4D97-B21C-E12E9B11AF80

P577

Q28211825-5E1A0BA0-5294-4DD1-A610-D4DF6CA89E95

P698

Q28211825-AB6E98C3-CFEE-4980-8071-A5163CA04A5A

P3181

P356

S0006-3223(03)00173-2

P1433

Biological Psychiatry

P1476

Interferon-alpha-induced chang ...... ssion and paroxetine treatment

@en

P2093

Andrew H Miller

http://www.w3.org/2001/XMLSchema#string

Charles B Nemeroff

http://www.w3.org/2001/XMLSchema#string

David H Lawson

http://www.w3.org/2001/XMLSchema#string

Dietmar Fuchs

http://www.w3.org/2001/XMLSchema#string

Dominique L Musselman

http://www.w3.org/2001/XMLSchema#string

Gabriele Neurauter

http://www.w3.org/2001/XMLSchema#string

P304

906-914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3586696

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0006-3223(03)00173-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14573318

http://www.w3.org/2001/XMLSchema#string